Fresenius v. Baxter: The Importance of Timing in Patent Litigation

by Akerman LLP

The Federal Circuit’s recent decision in Fresenius USA, Inc. v. Baxter Int’l, Inc., illustrates the potential value of challenging a patent's validity through administrative proceedings in the U.S. Patent & Trademark Office (USPTO), in parallel with pending federal litigation. The decision’s impact on patent litigation may be even more significant under the America Invents Act’s new USPTO patent review procedures, which have created more accelerated options to challenge the validity of a patent. 35 U.S.C. §§ 301-29 (2006).

After a long battle including multiple appeals, the validity of the patent in the Fresenius case had been upheld by the Court of Appeals of the Federal Circuit (CAFC), but the damages were not finalized and had been remanded. While in that procedural posture, a determination of patent invalidity, arising from a reexamination by the USPTO, was affirmed by the CAFC. The CAFC was then asked by Fresenius for a ruling dismissing the case, along with its holding of infringement, on the grounds that the federal case was not final, and that, during the cases' pendency, the patent had been invalidated, and, in essence, ceased to exist. The CAFC ruled in favor of Fresenius, holding that just because, as in this case, a final determination upholding patent validity had been made, so long as substantive aspects of the case remain pending, like a damages determination, then the decision is not final, and a final, affirmed administrative finding of invalidity acts to extinguish the pending patent case. Fresenius USA, Inc. v. Baxter Int’l, Inc., No. 2012-1334, -1335, 2013 U.S. App. LEXIS 13484 (Fed. Cir. July 2, 2013).

The Fresenius Ruling: When Is a Court’s Final Ruling Sufficiently Final to Block USPTO Decisions?

The Fresenius decision arose from a patent owned by Baxter International, Inc. for a hemodialysis machine, a machine that filters toxins from the bloodstream in place of kidneys. In 2003, Fresenius USA, Inc. brought an action against Baxter for a declaratory judgment of non-infringement and invalidity with respect to Baxter’s patents. Baxter brought a counterclaim for infringement against Fresenius, and Fresenius later stipulated to infringement after the court constructed Baxter’s patent claims unfavorably to Fresenius. After the stipulation, Fresenius was left having to prove that Baxter’s patents were invalid in order to avoid liability for infringement. Fresenius filed for patent reexamination in the USPTO while the district court litigation was underway.

By February of 2007, the district court ruled that Baxter’s patent claims were valid and Fresenius was liable for infringement. Fresenius appealed the court’s ruling. Later that year, the USPTO ruled that Baxter’s patents were invalid after reexamination, and Baxter appealed the USPTO ruling.

In 2009, the Federal Circuit affirmed the district court’s ruling that Baxter’s patents were "not invalid," but remanded the decision for the district court to determine Baxter’s remedy for patent infringement. In March of 2012, the district court awarded Baxter damages for infringement as well as millions of dollars in royalties on Fresenius’ infringing machines. Immediately after the court’s ruling on damages, Fresenius appealed the damages award, and the district court stayed execution of the judgment pending the outcome of the appeal. Months later in November of 2012, however, the Federal Circuit affirmed the USPTO’s ruling that Baxter’s patent was invalid, and the USPTO cancelled Baxter’s patent claims before the Federal Circuit could review the district court’s damage award.

During the appeal of the court’s damages award, Fresenius argued that because the USPTO cancelled Baxter’s patent claims, the federal courts could not impose a damages award against Fresenius for infringement since Baxter’s patent was now invalid, and the federal case had not been finally decided. Baxter, on the other hand, argued that the district court and Federal Circuit’s final judgment of validity barred the USPTO’s ruling of invalidity through the legal principle of res judicata, which prohibits parties from retrying the same claim in another forum. Thus, the issue arose whether a cancellation of patent claims in reexamination is binding in pending federal court litigation after the courts have issued a final judgment of patent validity.

The Federal Circuit first ruled that a federal court’s decision is only sufficiently final to prohibit a ruling on the same issue in the USPTO if all issues on the merits have been decided and there is “nothing for the court to do but execute the judgment.” Because the Federal Circuit had to resolve Fresenius and Baxter’s dispute over damages on appeal, the court still had to resolve issues in the case before a court could execute the judgment. Therefore, the Federal Circuit ruled that its prior ruling of validity was not sufficiently final to preclude a cancellation of Baxter’s patent claims in the USPTO.

The Federal Circuit then ruled that its decision to bind a federal court to the USPTO’s decision did not violate the separation of powers under the United States Constitution. The court reasoned that a violation of the separation of powers occurs if the executive or legislative branch retroactively compels a case to be reopened. Here, the case was not reopened since the Federal Circuit had yet to issue a final mandate ending the case. Moreover, the Court ruled that an appellate court must apply the laws in effect at the time it renders its decision. The law in effect at the time of the appeal was that Baxter’s patent claims had been cancelled and were no longer valid.

Judge Newman dissented arguing that the Federal Circuit’s decision to bind the courts to the USPTO’s reexamination decision violated the separation of powers under the Constitution. She reasoned that it is a violation of the Constitution for the executive branch to exercise judicial power by annulling a final judgment in federal court, and the Federal Circuit’s ruling allowed just that by making the USPTO’s decision binding after a federal court had already issued a final judgment on the patent’s validity. She also argued that the Federal Circuit’s decision was contrary to the law of res judicata and ran afoul of judicial policy favoring the finality of decisions after the issues in that decision had been fully litigated by both parties, as was the case in Baxter and Fresenius’ disagreement over the validity of Baxter’s patents.

Patent Litigation Strategy For Patent Holders and Accused Infringers After Fresenius

A. Patent Holders

Fresenius allows accused infringers to prevail in the court system by having the USPTO invalidate a patent before the courts have issued a final judgment and relief for patent infringement. The America Invents Act has increased the number of procedures available to accused infringers for invalidating patents, and has shortened the time to decision for certain of these procedures. Thus, the Fresenius decision requires patent holders to be aware of these new procedures and the timing of USPTO decisions from these procedures in relation to the timing of federal court decisions.

One option available to a patent holder is to stay federal court proceedings while the USPTO reexamines a patent’s validity so that the patent holder avoids any costly litigation that could be wasted if the USPTO invalidates its patent claims. Federal courts, however, will not always stay court proceedings while the USPTO reexamines a patent. The decision to stay court proceedings lies within a judge’s discretion, and courts balance three factors when determining whether to grant a stay: “(1) whether a stay would unduly prejudice or present a clear tactical disadvantage to the non-moving party; (2) whether a stay will simplify the issues in question and trial of the case; and (3) whether discovery is complete and whether a trial date has been set.” First Am. Title Ins. Co. v. Maclaren, L.L.C., C.A. No. 10-cv-363 (GMS), 2012 WL 769601, at *4 (D. Del. Mar. 9, 2012).

Another option is for a patent holder to secure a final ruling on the merits and damages as soon as possible so that the accused infringer does not have enough time to challenge the patent’s validity in the USPTO while a final judgment is pending. A patent holder may be able to achieve this goal by either delaying USPTO proceedings, by expediting federal court proceedings, or both. The ability to delay a USPTO proceeding depends on the type of proceeding, such as post-grant review, inter partes review, or ex parte reexamination. With respect to inter-partes review, for example, the USPTO must issue a decision within one year from the date the USPTO instituted review. 35 U.S.C. § 326(a)(11). A patent holder may delay the institution of post-grant review, however, by filing a preliminary response as late as possible since the USPTO does not have to decide whether to institute post-grant review until three months from the date of the preliminary response. Id. § 324(c). A patent holder may also appeal a decision of the USPTO to the Federal Circuit, which can further delay a final decision from the USPTO. Id. § 329. Familiarity with USPTO practice is crucial in the post-Fresenius legal landscape, since delaying USPTO proceedings could mean saving a patent from being invalidated and forfeiting any victory in federal court that is awaiting a decision on appeal.

Along with familiarity of USPTO procedure, patent holders should have a heightened awareness about litigation strategies that will delay a final judgment and therefore increase the chances that the opposing party can have the USPTO invalidate the patent and erase any victories in federal court. For example, a bifurcated trial may delay a final judgment on damages and give the accused infringer more time to invalidate the patent through USPTO procedures.

B. Accused Infringers

In cases where significant federal litigation is proceeding in parallel with related administrative review(s) in the USPTO, the Fresenius decision may give accused infringers more opportunity to  avoid liability for infringement, since, depending on timing of the parallel proceedings, accused infringers may have two chances to achieve invalidity of a patent in time to escape a holding of infringement—one chance in federal court, of course, but another chance in the USPTO, the latter opportunity potentially being more readily "in time" to effect the corresponding federal case.

Accused infringers likewise need to be aware of the new USPTO procedures under the America Invents Act. For accused infringers, Fresenius increases the importance of promptly filing an action in the USPTO to initiate post-grant review, inter partes review, or ex parte reexamination, so that a final decision in the court system does not issue before USPTO proceedings have concluded. As noted above, USPTO proceedings may take longer to complete if the accused infringer delays instituting the USPTO proceeding or responding to requests for information from the USPTO.

Accused infringers may also consider applying for a stay so that they do not waste resources defending a costly lawsuit against a patent holder whose patent may be invalidated by the USPTO.

One caveat to all parties, however, is the need to consider the rules for estoppel in availing oneself of administrative proceedings before the USPTO. See, e.g. 35 U.S.C. § 315(e). A USPTO ruling that a patent is valid after post-grant review or inter partes review generally will estop the accused party from bringing the same grounds for invalidity in a civil action claiming invalidity of the same patent. Id. § 315(e)(2); id. §  325(e)(2). A USPTO ruling that a patent is valid after an ex parte reexamination, however, does not bar an accused infringer from arguing invalidity in federal court. Id. §§ 301-306 (containing no statutory estoppel provisions that would bar a claim in federal court that was already argued during USPTO proceedings that resulted in a final decision). Thus, while Fresenius was a favorable ruling for accused infringers, accused infringers must tread carefully in the USPTO and fully understand the effect of estoppel from using such USPTO procedures.

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Akerman LLP | Attorney Advertising

Written by:

Akerman LLP

Akerman LLP on:

Readers' Choice 2017
Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up using*

Already signed up? Log in here

*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
Privacy Policy (Updated: October 8, 2015):

JD Supra provides users with access to its legal industry publishing services (the "Service") through its website (the "Website") as well as through other sources. Our policies with regard to data collection and use of personal information of users of the Service, regardless of the manner in which users access the Service, and visitors to the Website are set forth in this statement ("Policy"). By using the Service, you signify your acceptance of this Policy.

Information Collection and Use by JD Supra

JD Supra collects users' names, companies, titles, e-mail address and industry. JD Supra also tracks the pages that users visit, logs IP addresses and aggregates non-personally identifiable user data and browser type. This data is gathered using cookies and other technologies.

The information and data collected is used to authenticate users and to send notifications relating to the Service, including email alerts to which users have subscribed; to manage the Service and Website, to improve the Service and to customize the user's experience. This information is also provided to the authors of the content to give them insight into their readership and help them to improve their content, so that it is most useful for our users.

JD Supra does not sell, rent or otherwise provide your details to third parties, other than to the authors of the content on JD Supra.

If you prefer not to enable cookies, you may change your browser settings to disable cookies; however, please note that rejecting cookies while visiting the Website may result in certain parts of the Website not operating correctly or as efficiently as if cookies were allowed.

Email Choice/Opt-out

Users who opt in to receive emails may choose to no longer receive e-mail updates and newsletters by selecting the "opt-out of future email" option in the email they receive from JD Supra or in their JD Supra account management screen.


JD Supra takes reasonable precautions to insure that user information is kept private. We restrict access to user information to those individuals who reasonably need access to perform their job functions, such as our third party email service, customer service personnel and technical staff. However, please note that no method of transmitting or storing data is completely secure and we cannot guarantee the security of user information. Unauthorized entry or use, hardware or software failure, and other factors may compromise the security of user information at any time.

If you have reason to believe that your interaction with us is no longer secure, you must immediately notify us of the problem by contacting us at In the unlikely event that we believe that the security of your user information in our possession or control may have been compromised, we may seek to notify you of that development and, if so, will endeavor to do so as promptly as practicable under the circumstances.

Sharing and Disclosure of Information JD Supra Collects

Except as otherwise described in this privacy statement, JD Supra will not disclose personal information to any third party unless we believe that disclosure is necessary to: (1) comply with applicable laws; (2) respond to governmental inquiries or requests; (3) comply with valid legal process; (4) protect the rights, privacy, safety or property of JD Supra, users of the Service, Website visitors or the public; (5) permit us to pursue available remedies or limit the damages that we may sustain; and (6) enforce our Terms & Conditions of Use.

In the event there is a change in the corporate structure of JD Supra such as, but not limited to, merger, consolidation, sale, liquidation or transfer of substantial assets, JD Supra may, in its sole discretion, transfer, sell or assign information collected on and through the Service to one or more affiliated or unaffiliated third parties.

Links to Other Websites

This Website and the Service may contain links to other websites. The operator of such other websites may collect information about you, including through cookies or other technologies. If you are using the Service through the Website and link to another site, you will leave the Website and this Policy will not apply to your use of and activity on those other sites. We encourage you to read the legal notices posted on those sites, including their privacy policies. We shall have no responsibility or liability for your visitation to, and the data collection and use practices of, such other sites. This Policy applies solely to the information collected in connection with your use of this Website and does not apply to any practices conducted offline or in connection with any other websites.

Changes in Our Privacy Policy

We reserve the right to change this Policy at any time. Please refer to the date at the top of this page to determine when this Policy was last revised. Any changes to our privacy policy will become effective upon posting of the revised policy on the Website. By continuing to use the Service or Website following such changes, you will be deemed to have agreed to such changes. If you do not agree with the terms of this Policy, as it may be amended from time to time, in whole or part, please do not continue using the Service or the Website.

Contacting JD Supra

If you have any questions about this privacy statement, the practices of this site, your dealings with this Web site, or if you would like to change any of the information you have provided to us, please contact us at:

- hide
*With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name. Or, sign up using your email address.